BioLife Solutions
BLFS
187 hedge funds and large institutions have $1.18B invested in BioLife Solutions in 2025 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 59 increasing their positions, 74 reducing their positions, and 25 closing their positions.
0.91% more ownership
Funds ownership: 100.74% → 101.66% (+0.91%)
0% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 25
4% less capital invested
Capital invested by funds: $1.23B → $1.18B (-$43.9M)
3% less funds holding
Funds holding: 192 → 187 (-5)
20% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 74
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$29.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.9M |
| 3 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
+$9.91M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$8.71M |
| 5 |
BlackRock
New York
|
+$8.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$19.6M |
| 2 |
Rockefeller Capital Management
New York
|
-$7.96M |
| 3 |
D.E. Shaw & Co
New York
|
-$3.12M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.88M |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$2.84M |
BLFS Hedge Fund Activity: Q4 2025 in Review
187 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2025, worth a combined $1.18B — down 3.6% from $1.23B a quarter earlier.
Fund positioning in BLFS was balanced in Q4 2025: 25 funds opened new positions, 25 closed out, 59 added to existing stakes and 74 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $29.1M. The largest seller was Casdin Capital, cutting an estimated $19.6M.
- 187 institutional investors held BioLife Solutions (BLFS) as of Q4 2025, down from 192 in Q3 2025.
- Funds reported $1.18B of BioLife Solutions stock for Q4 2025, down 3.6% quarter-over-quarter.
- 25 funds opened new BioLife Solutions positions in Q4 2025 and 25 closed out, a net change of 0 holders.
- The largest BioLife Solutions buyer in Q4 2025 was T. Rowe Price Investment Management, an estimated $29.1M added.
- The largest BioLife Solutions seller in Q4 2025 was Casdin Capital, an estimated $19.6M sold.
Based on aggregated 13F filings for Q4 2025.